TCT-740 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy).

MLA

Raungaard, Bent, et al. “TCT-740 3-Year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy).” Journal of the American College of Cardiology (JACC), vol. 70, Nov. 2017, p. B314. EBSCOhost, https://doi.org/10.1016/j.jacc.2017.09.975.

APA

Raungaard, B., Jensen, L. O., Jensen, S. E., Hansen, H., Thuesen, L., Aaroe, J., Villadsen, A., Veien, K., Junker, A., Madsen, M., Maeng, M., Kristensen, S. D., & Christiansen, E. (2017). TCT-740 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy). Journal of the American College of Cardiology (JACC), 70, B314. https://doi.org/10.1016/j.jacc.2017.09.975

Chicago

Raungaard, Bent, Lisette Okkels Jensen, Svend Eggert Jensen, Henrik Hansen, Leif Thuesen, Jens Aaroe, Anton Villadsen, et al. 2017. “TCT-740 3-Year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy).” Journal of the American College of Cardiology (JACC) 70 (November): B314. doi:10.1016/j.jacc.2017.09.975.